FDA Home Page | CDRH Home Page | Search | A-Z Index

Nuflexxa (1% Sodium Hyaluronate) - P010029

Issued December 3, 2004

• Part 1 - Approval Order
• Part 2 - Summary of Safety and Effectiveness
• Part 3 - Professional Labeling
• Part 4 - Patient Labeling
• Other Consumer Information

This document is in a Portable Document Format (PDF). Acrobat Reader is required to read this document.

Updated August 24, 2006

CDRH Home Page | CDRH A-Z Index | Contact CDRH | Accessibility | Disclaimer
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA | HHS Home Page

Center for Devices and Radiological Health / CDRH